BNT327-05 Phase III, multisite, randomized, double-blind trial of BNT327 in combination with chemotherapy versus placebo with chemotherapy in participants with previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (TNBC) whose tumor PD-L1 status is considered negative.
- Phase III
- Trial Category: Breast
Contact(s)
Mary Beth Wilwerding, RN Admin@NEcancertrials.com
Location(s)
Available at Nebraska Cancer Specialists, Omaha and Grand Island, NE locations
Interested in More Information?
Please fill out the form below. Someone will get back to you as soon as possible.
"*" indicates required fields